These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Antithrombotic and antiplatelet therapies in relation to risk stratification in patients with non-ST elevation acute coronary syndrome: insights from the Sino-Global Registry of Acute Coronary Events. Zhang LJ, Chen YD, Song XT, Zhao FH, Lü SZ. Chin Med J (Engl); 2009 Mar 05; 122(5):502-8. PubMed ID: 19323898 [Abstract] [Full Text] [Related]
9. Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events. Collet JP, Montalescot G, Agnelli G, Van de Werf F, Gurfinkel EP, López-Sendón J, Laufenberg CV, Klutman M, Gowda N, Gulba D, GRACE Investigators. Eur Heart J; 2005 Nov 05; 26(21):2285-93. PubMed ID: 15932908 [Abstract] [Full Text] [Related]
10. Early glycoprotein IIb/IIIa inhibitor use for non-ST-segment elevation acute coronary syndrome: patient selection and associated treatment patterns. Hoekstra JW, Roe MT, Peterson ED, Menon V, Mulgund J, Pollack CV, Miller C, Palabrica T, Harrington RA, Ohman EM, Gibler WB. Acad Emerg Med; 2005 May 05; 12(5):431-8. PubMed ID: 15863399 [Abstract] [Full Text] [Related]
12. Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative). Alexander D, Mann N, Ou FS, Peterson ED, Ohman EM, Gibler WB, Roe MT. Am J Cardiol; 2008 Nov 15; 102(10):1335-40. PubMed ID: 18993151 [Abstract] [Full Text] [Related]
17. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis. O'Donoghue M, Antman EM, Braunwald E, Murphy SA, Steg PG, Finkelstein A, Penny WF, Fridrich V, McCabe CH, Sabatine MS, Wiviott SD. J Am Coll Cardiol; 2009 Aug 18; 54(8):678-85. PubMed ID: 19679245 [Abstract] [Full Text] [Related]
19. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study. Savonitto S, Ambrosini V, Marzocchi A, Tolaro S, Petronio AS, Galassi AR, Bongo AS, Gaglione A, Bolognese L, IDEA Survey Investigators, Italian Society of Invasive Cardiology. Ital Heart J; 2005 Feb 18; 6(2):106-18. PubMed ID: 15819503 [Abstract] [Full Text] [Related]
20. In-hospital management and mortality in elderly patients with non-ST-segment elevation acute coronary syndromes treated in centers without on-site invasive facilities. Dziewierz A, Siudak Z, Rakowski T, Zdzienicka J, Dykla D, Mielecki W, Dubiel JS, Dudek D. Cardiol J; 2008 Feb 18; 15(5):451-7. PubMed ID: 18810721 [Abstract] [Full Text] [Related] Page: [Next] [New Search]